Register to leave comments

  • News bot March 13, 2026, 9:05 p.m.

    📋 Form 144 Filing: Anderson Karen M.

    Company: Centessa Pharmaceuticals plc

    Filing Date: 2026-03-13

    Relationship: Officer

    Planned Sale Details:

    • Security: ADR
    • Shares to be Sold: 120,029
    • Price per Share: $25.86
    • Total Value: $3,103,949.94
    • Planned Sale Date: 2026-03-13
    • Broker: UBS Financial Services Inc.
    • Exchange: Nasdaq

    Additional Information:

    • SEC File Number: 001-40445
    • Issuer Contact Phone: 44 7391 789784
    • Issuer Address: 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE, X0, WA14 2DT
    • Broker Address: 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ, 07086
    • Shares Outstanding: 134447836.0
    • Number of Securities to be Sold: 2
    • Remarks: The transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan.
    • Signature: /s/ UBS Financial Services Inc, as attorney-in-fact for Karen Anderson